Skip to main content

Table 11 Fluctuations in SpO2 among the study participants (%)

From: Comparative study of the efficacy and safety of remimazolam and midazolam for general anesthesia in elderly patients: a randomized controlled trial

Group

T0

T1

T2

T3

T4

T5

T6

T7

T8

T9

T10

Remimazolam

97.48 ± 1.859

99.43 ± 0.729

99.61 ± 0.649

99.61 ± 0.774

99.61 ± 0.774

99.57 ± 0.981

97.87 ± 2.754

96.52 ± 2.934

97.91 ± 2.169

98.22 ± 2.107

96.96 ± 2.241

Midazolam

98.02 ± 1.491

99.10 ± 1.261

99.74 ± 0.443

99.74 ± 0.527

99.74 ± 0.527

99.24 ± 2.404

98.64 ± 2.456

98.02 ± 1.813

98.24 ± 1.956

98.48 ± 2.112

97.98 ± 2.564

p value

0.121

0.109

0.254

0.338

0.338

0.395

0.151

0.004

0.440

0.544

0.041

  1. Data are presented as the mean ± SD